Stock Events

Stock Events

GlobeStar Therapeutics 

$0.000100
8
+$0.00+0%Tuesday 20:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0001
52W Low
0.0001
Volume
300,000
Avg. Volume
0
Mkt Cap
124,110.6
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Aug 22Expected
Q4 2020
Q4 2020
Q1 2021
Q2 2021
Q4 2021
Q1 2022
Q2 2022
-0.01
-0.01
-0
0
Expected EPS
N/A
Actual EPS
-0.0002

Financials

-Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
0Revenue
-1.95MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Vertex Pharmaceuticals
VRTX
Mkt Cap127.93B
Vertex Pharmaceuticals is a competitor because it focuses on creating transformative medicines for serious diseases, similar to GlobeStar's mission in the therapeutics space.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences is a biopharmaceutical company that competes with GlobeStar Therapeutics in the development and commercialization of innovative therapies.
Regeneron Pharmaceuticals
REGN
Mkt Cap75.69B
Regeneron Pharmaceuticals is involved in the discovery, development, and commercialization of pharmaceutical products for the treatment of serious medical conditions, competing with GlobeStar Therapeutics.
AMGEN
AMGN
Mkt Cap217.9B
Amgen is a biotechnology company that develops and produces medicines, directly competing with GlobeStar Therapeutics in the biopharmaceutical sector.
Biogen
BIIB
Mkt Cap32.49B
Biogen competes with GlobeStar Therapeutics by focusing on neurology, and the development of therapies for neurological and neurodegenerative conditions.
Novartis
NVS
Mkt Cap268B
Novartis is a global healthcare company that competes across multiple segments, including those targeted by GlobeStar Therapeutics, with a broad portfolio of innovative medicines.
Merck
MRK
Mkt Cap356.01B
Merck & Co., Inc. is a global healthcare company that develops medicines, vaccines, biologic therapies, and animal health products, competing with GlobeStar Therapeutics in the healthcare sector.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a research-based biopharmaceutical company that competes with GlobeStar Therapeutics in the discovery, development, and manufacture of healthcare products.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca is a global, science-led biopharmaceutical business that competes with GlobeStar Therapeutics in developing a range of therapies, including those for cancer and other diseases.

About

GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021. Its operations are headquartered in Richland, Washington.
Show More
CEO
James C. Katzaroff
Country
United States
ISIN
US37960P1049

Listings

OTC Link
US
GSTC

0 Comments

Share your thoughts

FAQs

What is GlobeStar Therapeutics stock price today?▼
The current price of GSTC is $0.00 USD — it has increased by +0% in the past 24 hours. Watch GlobeStar Therapeutics stock price performance more closely on the chart.
What is GlobeStar Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange GlobeStar Therapeutics stocks are traded under the ticker GSTC.
Is GlobeStar Therapeutics stock price growing?▼
GSTC stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year GlobeStar Therapeutics has showed a +0% increase.
What is GlobeStar Therapeutics market cap?▼
Today GlobeStar Therapeutics has the market capitalization of 124,110.6
What were GlobeStar Therapeutics earnings last quarter?▼
GSTC earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is GlobeStar Therapeutics revenue for the last year?▼
GlobeStar Therapeutics revenue for the last year amounts to 0 USD.
What is GlobeStar Therapeutics net income for the last year?▼
GSTC net income for the last year is -1.95M USD.
In which sector is GlobeStar Therapeutics located?▼
GlobeStar Therapeutics operates in the Health & Wellness sector.
When did GlobeStar Therapeutics complete a stock split?▼
GlobeStar Therapeutics has not had any recent stock splits.
Where is GlobeStar Therapeutics headquartered?▼
GlobeStar Therapeutics is headquartered in New York, United States.